期刊
CANCER JOURNAL
卷 13, 期 6, 页码 345-348出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PPO.0b013e31815a7b69
关键词
tumor; angiogenesis; vascular endothelial growth factor (VEGF); VEGF receptor-1; VEGF receptor-2
类别
The identification and characterization of several important regulators of angiogenesis, which led to Food and Drug Administration approval of the first antiangiogenic drugs, has opened a new era in cancer therapy. This article focuses on the clinical progress in targeting one of the major regulators of angiogenesis, vascular endothelial growth factor-A and also discusses some recent advances in the elucidation of potential cellular and molecular mechanisms underlying refiractoriness or resistance to antiangiogenic therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据